MYC and parasitic infectious disease: Notably, PfEXP2-HAglmS/RESA5′-EXP2-cMyc parasites were able to complete cycle 1 and reinvade new RBCs following GlcN treatment (Figure 7D), and, although the parasitemia was lower than PfEXP2-HAglmS/pEXP2-cMyc at day 6, the difference was not statistically significant (Figure 7E).